147 related articles for article (PubMed ID: 38372273)
1. High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018.
Stefanos R; Lewis RM; Querec TD; Gargano JW; Unger ER; Markowitz LE
Hum Vaccin Immunother; 2024 Dec; 20(1):2308378. PubMed ID: 38372273
[TBL] [Abstract][Full Text] [Related]
2. Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey.
McClung NM; Lewis RM; Gargano JW; Querec T; Unger ER; Markowitz LE
J Adolesc Health; 2019 Dec; 65(6):715-722. PubMed ID: 31515134
[TBL] [Abstract][Full Text] [Related]
3. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.
Hirth J; McGrath CJ; Kuo YF; Rupp RE; Starkey JM; Berenson AB
Vaccine; 2018 Nov; 36(50):7682-7688. PubMed ID: 30377066
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United States.
Saadeh K; Park I; Gargano JW; Whitney E; Querec TD; Hurley L; Silverberg M
Vaccine; 2020 Jan; 38(1):39-45. PubMed ID: 31611099
[TBL] [Abstract][Full Text] [Related]
5. Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women.
Whittemore D; Ding L; Widdice LE; Brown DA; Bernstein DI; Franco EL; Kahn JA
J Womens Health (Larchmt); 2016 Nov; 25(11):1153-1158. PubMed ID: 27754751
[TBL] [Abstract][Full Text] [Related]
6. Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes.
Montealegre JR; Varier I; Bracamontes CG; Dillon LM; Guillaud M; Sikora AG; Follen M; Adler-Storthz K; Scheurer ME
Ethn Health; 2019 Oct; 24(7):804-815. PubMed ID: 28870103
[No Abstract] [Full Text] [Related]
7. Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018.
Rosenblum HG; Lewis RM; Gargano JW; Querec TD; Unger ER; Markowitz LE
MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):415-420. PubMed ID: 33764964
[TBL] [Abstract][Full Text] [Related]
8. Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management.
Mix J; Saraiya M; Hallowell BD; Befano B; Cheung LC; Unger ER; Gargano JW; Markowitz LE; Castle PE; Raine-Bennett T; Walker J; Zuna R; Schiffman M; Wentzensen N; Gage JC
J Natl Cancer Inst; 2022 Jun; 114(6):845-853. PubMed ID: 35176161
[TBL] [Abstract][Full Text] [Related]
9. Disparities in human papillomavirus vaccination coverage in the United States, National Health and Nutrition Examination Survey, January 2017-March 2020.
Lewis RM; Markowitz LE
Vaccine; 2022 May; 40(20):2828-2832. PubMed ID: 35393147
[TBL] [Abstract][Full Text] [Related]
10. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.
Markowitz LE; Hariri S; Lin C; Dunne EF; Steinau M; McQuillan G; Unger ER
J Infect Dis; 2013 Aug; 208(3):385-93. PubMed ID: 23785124
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus Vaccination Initiation Among Sexual Orientation Identity and Racial/Ethnic Subgroups of Black and White U.S. Women and Girls: An Intersectional Analysis.
Agénor M; Pérez AE; Peitzmeier SM; Potter J; Borrero S
J Womens Health (Larchmt); 2018 Nov; 27(11):1349-1358. PubMed ID: 29957092
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of quadrivalent HPV vaccination in reducing vaccine-type and nonvaccine-type high risk HPV infection.
Li C; Hall TG; Hall JJ; He WQ
Epidemiol Infect; 2023 Feb; 151():e37. PubMed ID: 36789960
[TBL] [Abstract][Full Text] [Related]
13. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
14. Racial and Ethnic Group Knowledge, Perceptions and Behaviors about Human Papillomavirus, Human Papillomavirus Vaccination, and Cervical Cancer among Adolescent Females.
Bond SM; Cartmell KB; Lopez CM; Ford ME; Brandt HM; Gore EI; Zapka JG; Alberg AJ
J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):429-435. PubMed ID: 26915922
[TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018.
Rosenblum HG; Lewis RM; Gargano JW; Querec TD; Unger ER; Markowitz LE
Ann Intern Med; 2022 Jul; 175(7):918-926. PubMed ID: 35576590
[TBL] [Abstract][Full Text] [Related]
16. Update of HPV-associated female genital cancers in the United States, 1999-2004.
Watson M; Saraiya M; Wu X
J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.
Oliver SE; Unger ER; Lewis R; McDaniel D; Gargano JW; Steinau M; Markowitz LE
J Infect Dis; 2017 Sep; 216(5):594-603. PubMed ID: 28931217
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Human Papillomavirus in Self-Collected Cervicovaginal Swabs in Young Women in the United States Between 2003 and 2012.
Tarney CM; Klaric J; Beltran T; Pagan M; Han J
Obstet Gynecol; 2016 Dec; 128(6):1241-1247. PubMed ID: 27824760
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Oral Human Papillomavirus Infection: Impact of Sex, Race/Ethnicity, and Vaccination Status.
Berenson AB; Hirth JM; Chang M
Clin Infect Dis; 2022 Apr; 74(7):1230-1236. PubMed ID: 34218280
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
